BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of IPSC-derived BCMA CAR-iNKT Cell

BusinesswireDec 13 07:51 ET

BrightPath Biotherapeutics: Confirmation letter

EDINETNov 8 01:35 ET · Announcements

BrightPath Biotherapeutics: Half Year Report - Term 22 (2024/04/01 - 2025/03/31)

EDINETNov 8 01:34 ET · Announcements

BrightPath Biothera Sees Parent FY Loss Y927.00M

Dow JonesNov 8 01:32 ET

BrightPath Biotherapeutics: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)

JPXNov 8 01:30 ET · Announcements

Morinaga Milk, mcdonald's, Toyo Suisan, Eisai (8th) (1429-5463)

※Please note that the above calendar is tentative and subject to change based on the company's convenience. --------------------------------------- November 8th (Fri) <1429> Japan Aqua <1435> RoboHome <143A> Ishin <1450> Tanaka Construction Industry <1451> KHC <1518> Mitsui Matsushima HD <151A> Dai <167A> Ryo

Fisco JapanNov 7 16:30 ET